Sun Pharma adds $1.6m sterile manufacturing line in Guwahati, India

By Flora Southey contact

- Last updated on GMT

(Image: Getty/dk_photos)
(Image: Getty/dk_photos)

Related tags: Sun pharma, India

Sun Pharma has installed a parenteral drug production line in Guwahati for the manufacture of sterile products.

According to the firm, the Rs 120 crores ($1.6m) investment will enhance Sun Pharma’s capacity to manufacture lyophilized vials, liquid ampoules, and eye drops at the 14-acre Guwahati site.

Located in India’s eastern state of Assam, the Guwahati facility also houses granulation, tablet compression, and capsule filling capabilities.

Sun Pharma’s managing director, Dilip Shanghvi, said this latest investment responds to a governmental push for increased industrial activities and employment opportunities in Assam.

“Sun Pharma is committed to the government’s ‘Make in India’ initiative,” ​Shanghvi told delegates at the production line launch.

“In the next few years, the Guwahati plant is expected to become of the largest facilities in our network to manufacture sterile products,” ​he added.

Despite manufacturing setbacks in Gujarat​ and Halol​ earlier in the year, Sun Pharma recently announced regulatory success in the US for two separate drug products.

In August, the firm launched​ its extended-release Kapspargo Sprinkle drug product for the treatment of hypertension, angina pectoris or heart failure.

The following month, Sun Pharma announced​ its eye disease treatment, Cequa (cyclosporine ophthalmic solution) had received US Food and Drug Administration approval. 

Related news

Show more

Related products

show more

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Related suppliers